| Detected | Trial | Change |
|---|---|---|
| 2026-05-30 | NCT05503030 Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in… |
Trial completed |
| 2026-05-16 | NCT07335562 A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel /… |
Recruitment opened |
| 2026-05-16 | NCT07454291 A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in… |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-15 | NCT07588646 Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In… | Phase 1 | Completed |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06297096 | Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and… | Systemic Sclerosis | Recruiting |
| NCT07335562 | A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel /… | Systemic Sclerosis | Recruiting |
| Phase 2 | |||
| NCT04976036 | Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic… | Telangiectasia, Hereditary Hemorrhagic | Recruiting |
| Phase 1/2 | |||
| NCT03377023 | Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell… | Non Small Cell Lung Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT07454291 | A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in… | Idiopathic Pulmonary Fibrosis | Recruiting |
| Not specified | |||
| NCT04325217 | Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma… | Lung Diseases, Interstitial | Active, Not Recruiting |